We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

NasdaqGM - Delayed Quote USD

Denali Capital Acquisition Corp. (DECAW)

0.0388

+0.0005

+(1.31%)

At close: 4:00:00 PM EDT

Key Events

Loading Chart for DECAW

Previous Close 0.0383
Open 0.0396
Bid --
Ask --
Day's Range 0.0388 - 0.0396
52 Week Range 0.0388 - 0.0396
Volume 11,249
Avg. Volume --
Market Cap (intraday) --
Beta (5Y Monthly) 0.33
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. It intends to complete a business combination with companies primarily operating in the technology, consumer services, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.

--

Full Time Employees

--

Fiscal Year Ends

Financial Services

Sector

Shell Companies

Industry

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination

Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Top Midday Gainers

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Denali Capital Acquisition Corp.

0.0388

+1.31%

Mkt Cap -

Industry Shell Companies

Launch One Acquisition Corp.

0.1399

+25.58%

Mkt Cap -

Industry Shell Companies

Newbury Street II Acquisition Corp

0.1600

0.00%

Mkt Cap -

Industry Shell Companies

GP-Act III Acquisition Corp.

0.2000

0.00%

Mkt Cap -

Industry Shell Companies

Lionheart Holdings

0.1300

+12.65%

Mkt Cap -

Industry Shell Companies

Vine Hill Capital Investment Corp.

0.1788

0.00%

Mkt Cap -

Industry Shell Companies

Melar Acquisition Corp. I

0.1201

0.00%

Mkt Cap 2.072M

Industry Shell Companies

Valuation Measures

    Annual 

As of

Market Cap

--
Enterprise Value

--
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

--
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-3.45%
Return on Equity (ttm)

--
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-167.31k
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

16.87k
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-98.79k

DECA Denali Capital Acquisition Corp.

11.43

-3.22%

BNIXW Bannix Acquisition Corp.

0.0304

0.00%

EGUVF

0.0300

0.00%

CLRCW ClimateRock

0.0299

0.00%

DAVEW Dave Inc.

0.1551

-3.06%

CELUW Celularity Inc.

0.0400

+11.11%

SCLXW Scilex Holding Company

0.0620

-10.14%

FTIIW FutureTech II Acquisition Corp.

0.0440

+109.52%

DISTW Distoken Acquisition Corporation

0.0300

+20.00%

DFLIW Dragonfly Energy Holdings Corp.

0.0229

-11.92%

DRMAW Dermata Therapeutics, Inc.

0.0180

+20.00%

AOGOW Arogo Capital Acquisition Corp.

0.0300

0.00%

GBBKW Global Blockchain Acquisition Corp.

0.0027

+800.00%

HCVIW Hennessy Capital Investment Corp. VI

0.1500

+50.00%

MSSAW Metal Sky Star Acquisition Corporation

0.0200

0.00%

IGTAW Inception Growth Acquisition Limited

0.0301

-72.00%